EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Higher Cumulative Cytarabine Consolidation Improves Survival in Older Adults with Acute Myeloid Leukemia

Todd William Mudd iD, Kendall Diebold iD, Sravanti Rangaraju iD, Aditi Sharma, Kimo Bachiashvili, Pankit Vachhani, Manuel R Espinoza-Gutarra, Razan Mohty iD, Ravi Bhatia, Jorge Cortes iD, Omer Jamy iD

Cancers · 03.06.2026 · 18 (11) · 1831

DOI: 10.3390/cancers18111831 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 03.06.2026. Verfasst von Todd William Mudd und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Post-remission cytarabine consolidation is a cornerstone of therapy for acute myeloid leukemia (AML), but the optimal dosing strategy in older adults (≥60 years) remains unclear. High-dose cytarabine (HiDAC) is often avoided due to toxicity concerns, and data guiding cumulative dosing are limited.

Methods

We conducted a single-center retrospective cohort study of 111 patients aged ≥60 years with AML who achieved complete remission after standard 7 + 3 induction and received at least one cycle of cytarabine consolidation between 2012 and 2024. A 90-day landmark analysis excluded early relapses or deaths.

Results

The median age was 65 years; 41% proceeded to allogeneic hematopoietic stem cell transplantation (allo-SCT). Cytarabine consolidation was well tolerated, with no neurotoxicity and only one instance of reversible nephrotoxicity. Patients were stratified by median cumulative cytarabine dose into low-intensity (

Schlagwörter

Stichwörter der Autor:innen

AMLconsolidationcytarabineolder adults

Autor:innen und Institutionen

  • Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

ORCID-Profile: Todd William Mudd, Kendall Diebold, Sravanti Rangaraju, Razan Mohty, Jorge Cortes, Omer Jamy

Zitieren

APA

Mudd, T. W., Diebold, K., Rangaraju, S., Sharma, A., Bachiashvili, K., Vachhani, P., Espinoza-Gutarra, M. R., Mohty, R., Bhatia, R., Cortes, J., & Jamy, O. (2026). Higher Cumulative Cytarabine Consolidation Improves Survival in Older Adults with Acute Myeloid Leukemia. Cancers, 18(11), 1831. https://doi.org/10.3390/cancers18111831

Vancouver

Mudd TW, Diebold K, Rangaraju S, Sharma A, Bachiashvili K, Vachhani P, et al. Higher Cumulative Cytarabine Consolidation Improves Survival in Older Adults with Acute Myeloid Leukemia. Cancers. 2026;18(11):1831. doi:10.3390/cancers18111831

BibTeX
@article{Mudd2026,
  author = {Mudd, Todd William and Diebold, Kendall and Rangaraju, Sravanti and Sharma, Aditi and Bachiashvili, Kimo and Vachhani, Pankit and Espinoza-Gutarra, Manuel R and Mohty, Razan and Bhatia, Ravi and Cortes, Jorge and Jamy, Omer},
  title = {Higher Cumulative Cytarabine Consolidation Improves Survival in Older Adults with Acute Myeloid Leukemia},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {11},
  pages = {1831},
  doi = {10.3390/cancers18111831}
}
Kostenlos starten →